Yuji Nishimoto Selected Research

Yuji Nishimoto Research Topics

7	Venous Thromboembolism 10/2022 - 01/2020
7	Neoplasms (Cancer) 10/2022 - 04/2019
6	Hemorrhage 10/2022 - 01/2020
4	COVID-19 10/2022 - 01/2022
4	Thromboembolism 01/2020 - 01/2019
3	Thrombosis (Thrombus) 10/2022 - 01/2016
2	Thrombophilia 01/2022 - 04/2019
2	Critical Illness (Critically Ill) 01/2022 - 09/2020
2	Neointima 09/2017 - 05/2015
2	Acute Coronary Syndrome 09/2017 - 05/2014
2	Hyperplasia 09/2017 - 01/2016
2	Death (Near-Death Experience) 01/2017 - 05/2015
2	Myocardial Infarction 01/2017 - 05/2015
1	Infections 10/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	May-Thurner Syndrome 10/2021
1	Rupture 08/2021
1	Ischemia 01/2021
1	Heart Failure 12/2020
1	Pulmonary Embolism 11/2019
1	Neoplasm Metastasis (Metastasis) 10/2019
1	Chronic Renal Insufficiency 04/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Atherosclerosis 05/2015
1	Unstable Angina 05/2015

4	vinyltriethoxysilane (VTES)IBA 01/2020 - 01/2019
2	fibrin fragment D (D-dimer)IBA 07/2022 - 05/2022
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 05/2015
1	AnticoagulantsIBA 10/2022
1	Heparin (Liquaemin)FDA LinkGeneric 02/2022
1	C-Reactive ProteinIBA 12/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2019
1	MetalsIBA 09/2017
1	BESIBA 09/2017
1	omega-Chloroacetophenone (Mace)IBA 01/2017
1	LipidsIBA 05/2014

9	Therapeutics 10/2022 - 05/2015
3	Stents 09/2017 - 05/2015
3	Drug-Eluting Stents 09/2017 - 05/2015
2	Thrombectomy 10/2021 - 01/2021
1	Extracorporeal Membrane Oxygenation 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Conservative Treatment 08/2021
1	Vena Cava Filters (Inferior Vena Cava Filter) 12/2020
1	Enteral Nutrition (Feeding, Tube) 09/2020
1	Secondary Prevention 01/2020
1	Drug Therapy (Chemotherapy) 10/2019
1	Central Venous Catheters 05/2019